Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Total 13F shares
-
6,825,579
-
Share change
-
-99,141
-
Total reported value
-
$58,765,332
-
Price per share
-
$8.61
-
Number of holders
-
27
-
Value change
-
-$771,809
-
Number of buys
-
8
-
Number of sells
-
14
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2018
As of 31 Mar 2018,
SINOVAC BIOTECH LTD. - Common Shares (SVA) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,825,579 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Neumann Advisory Hong Kong Ltd, DEUTSCHE BANK AG\, Eqis Capital Management, Inc., STATE STREET CORP, Invesco Ltd., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Spark Investment Management LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.